CY1115010T1 - ΕΝΑΣ ΜΟΛΥΣΜΑΤΙΚΟΣ cDNA ΚΛΩΝΟΣ ΤΟΥ ΙΟΥ ΤΟΥ ΧΟΙΡΕΙΟΥ ΑΝΑΠΑΡΑΓΩΓΙΚΟΥ ΚΑΙ ΑΝΑΠΝΕΥΣΤΙΚΟΥ ΣΥΝΔΡΟΜΟΥ ΒΟΡΕΙΟΥ ΑΜΕΡΙΚΗΣ (PRRS) ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ - Google Patents
ΕΝΑΣ ΜΟΛΥΣΜΑΤΙΚΟΣ cDNA ΚΛΩΝΟΣ ΤΟΥ ΙΟΥ ΤΟΥ ΧΟΙΡΕΙΟΥ ΑΝΑΠΑΡΑΓΩΓΙΚΟΥ ΚΑΙ ΑΝΑΠΝΕΥΣΤΙΚΟΥ ΣΥΝΔΡΟΜΟΥ ΒΟΡΕΙΟΥ ΑΜΕΡΙΚΗΣ (PRRS) ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥInfo
- Publication number
- CY1115010T1 CY1115010T1 CY20141100252T CY141100252T CY1115010T1 CY 1115010 T1 CY1115010 T1 CY 1115010T1 CY 20141100252 T CY20141100252 T CY 20141100252T CY 141100252 T CY141100252 T CY 141100252T CY 1115010 T1 CY1115010 T1 CY 1115010T1
- Authority
- CY
- Cyprus
- Prior art keywords
- north american
- american prrs
- viral vectors
- viruses
- prrs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10041—Use of virus, viral particle or viral elements as a vector
- C12N2770/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
- C12N2770/10062—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
Abstract
Η εφεύρεση παρέχει απομονωμένα πολυνουκλεοτιδικά μόρια, συμπεριλαμβανομένων πλασμιδίων, ιικών φορέων, επιμολυσμένων κυττάρων ξενιστών που περιλαμβάνουν μια DNA ακολουθία που κωδικοποιεί μία μολυσματική RNA ακολουθία που κωδικοποιεί ένα ιό PRRS Βορείου Αμερικής, και επίσης PRRS ιούς Βορείου Αμερικής που κωδικοποιούνται από αυτή. Η εφεύρεση περαιτέρω παρέχει απομονωμένα μολυσματικά RNA μόρια που κωδικοποιούν ένα PRRS ιό Βορείου Αμερικής. Η εφεύρεση επίσης παρέχει απομονωμένα πολυνουκλεοτιδικά μόρια, μολυσματικά RNA μόρια, ιικούς φορείς και επιμολυσμένα κύτταρα ξενιστές που κωδικοποιούν γενετικά τροποποιημένους PRRS ιούς Βορείου Αμερικής, και γενετικά τροποποιημένους PRRS ιούς Βορείου Αμερικής που κωδικοποιούνται από αυτά. Η εφεύρεση επίσης παρέχει εμβόλια που περιλαμβάνουν τέτοια πλασμίδια, RNA μόρια, ιικούς φορείς και PRRS ιούς Βορείου Αμερικής και μεθόδους που χρησιμοποιούν αυτά τα εμβόλια σε χοίρους και σε άλλα ζώα. Επίσης παρέχονται απομονωμένα πολυνουκλεοτιδικά μόρια, ιικοί φορείς και επιμολυσμένα κύτταρα ξενιστές που περιλαμβάνουν μία νουκλεοτιδική ακολουθία που κωδικοποιεί ένα πεπτίδιο του ιού PRRS Βορείου Αμερικής. Αυτοί οι ιικοί φορείς και οι επιμολυσμένες κυτταρικές σειρές ξενιστές είναι χρήσιμοι για την προμήθεια πεπτιδίων για να αντισταθμίσουν πεπτίδια που κωδικοποιούνται από μεταλλαγμένες DNA ακολουθίες που κωδικοποιούν γενετικά τροποποιημένους PRRS ιούς Βορείου Αμερικής έτσι ώστε να μπορούν να δημιουργηθούν λειτουργικά ιοσωμάτια.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11334598P | 1998-12-22 | 1998-12-22 | |
EP20050018141 EP1627919B1 (en) | 1998-12-22 | 1999-11-25 | An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115010T1 true CY1115010T1 (el) | 2016-12-14 |
Family
ID=22348908
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY061100160T CY1105680T1 (el) | 1998-12-22 | 2006-02-07 | Μολυσματικος κλωνος cdna βορειοαμερικανικου ιου χοιρειου αναπαραγωγικου και αναπνευστικου συνδρομου (prrs) και χρησεις αυτου |
CY20141100252T CY1115010T1 (el) | 1998-12-22 | 2014-04-03 | ΕΝΑΣ ΜΟΛΥΣΜΑΤΙΚΟΣ cDNA ΚΛΩΝΟΣ ΤΟΥ ΙΟΥ ΤΟΥ ΧΟΙΡΕΙΟΥ ΑΝΑΠΑΡΑΓΩΓΙΚΟΥ ΚΑΙ ΑΝΑΠΝΕΥΣΤΙΚΟΥ ΣΥΝΔΡΟΜΟΥ ΒΟΡΕΙΟΥ ΑΜΕΡΙΚΗΣ (PRRS) ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY061100160T CY1105680T1 (el) | 1998-12-22 | 2006-02-07 | Μολυσματικος κλωνος cdna βορειοαμερικανικου ιου χοιρειου αναπαραγωγικου και αναπνευστικου συνδρομου (prrs) και χρησεις αυτου |
Country Status (18)
Country | Link |
---|---|
US (2) | US6500662B1 (el) |
EP (2) | EP1018557B9 (el) |
JP (7) | JP4113642B2 (el) |
CN (1) | CN1171996C (el) |
AR (2) | AR025146A1 (el) |
AT (1) | ATE309364T1 (el) |
AU (1) | AU769841B2 (el) |
BR (1) | BRPI9905902B8 (el) |
CA (2) | CA2290220C (el) |
CY (2) | CY1105680T1 (el) |
DE (1) | DE69928209T9 (el) |
DK (2) | DK1627919T3 (el) |
ES (2) | ES2251162T3 (el) |
HK (1) | HK1029140A1 (el) |
MX (1) | MXPA03009354A (el) |
NZ (2) | NZ513289A (el) |
PT (1) | PT1627919E (el) |
ZA (1) | ZA997289B (el) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
WO2000053787A1 (en) | 1999-03-08 | 2000-09-14 | Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. | Prrsv vaccines |
US7691389B2 (en) * | 1998-12-22 | 2010-04-06 | Pfizer Inc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7618797B2 (en) * | 1998-12-22 | 2009-11-17 | Pfizer Inc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
WO2000065032A1 (en) | 1999-04-22 | 2000-11-02 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
JPWO2002038753A1 (ja) * | 2000-11-09 | 2004-03-18 | 渡辺 純一 | 病原体に感染した動物の病態または生存に影響を与える遺伝子のスクリーニング方法 |
US6841364B2 (en) * | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
US7906311B2 (en) * | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
RU2354399C2 (ru) * | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
US7611717B2 (en) | 2004-06-18 | 2009-11-03 | Regents Of The University Of Minnesota | Identifying virally infected and vaccinated organisms |
KR100872840B1 (ko) | 2004-07-09 | 2008-12-22 | (주)씨아이디 | 돼지생식기호흡기증후군 바이러스에 대한 전체-길이의감염성이 있는 cDNA 클론 및 이의 용도 |
US7632636B2 (en) * | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
US7879337B2 (en) * | 2004-11-11 | 2011-02-01 | Pfizer Inc. | Mutant porcine reproductive and respiratory syndrome virus |
DE602006013270D1 (en) | 2005-01-13 | 2010-05-12 | Boehringer Ingelheim Vetmed | Prrs-impfstoffe |
KR100996105B1 (ko) * | 2005-02-25 | 2010-11-22 | 화이자 프로덕츠 인크. | 돼지 생식기 호흡기 증후군 바이러스의 n 단백질돌연변이체 |
UA95778C2 (ru) * | 2005-06-24 | 2011-09-12 | Риджентс Оф Зе Юниверсити Оф Миннесота | Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения |
BRPI0615610A2 (pt) * | 2005-08-30 | 2011-05-24 | Univ Nebraska | processos e composições para vacinação de animais com antìgenos de prrsv com maior imunogenicidade |
US8202717B2 (en) | 2007-01-12 | 2012-06-19 | The Board Of Trustees Of The University Of Illinois | Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus |
US7666585B2 (en) | 2007-06-15 | 2010-02-23 | Protatek International, Inc. | Construction of chimera PRRSV, compositions and vaccine preparations |
CN101848995A (zh) * | 2007-06-25 | 2010-09-29 | 南达科他州立大学 | 重组的北美1型猪繁殖与呼吸综合征病毒及使用方法 |
RU2561595C2 (ru) * | 2008-08-25 | 2015-08-27 | Бёрингер Ингельхайм Ветмедика, Инк. | Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) |
US8012735B2 (en) * | 2009-03-02 | 2011-09-06 | University Of Kentucky Research Foundation | Infectious cDNA clone of the modified live virus vaccine strain of Equine arteritis virus |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
CN102573900B (zh) * | 2009-09-10 | 2017-05-31 | 梅里亚股份有限公司 | 包含含有皂苷的佐剂的新疫苗制剂 |
UA108902C2 (uk) * | 2010-11-10 | 2015-06-25 | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
EA031432B1 (ru) | 2011-02-17 | 2019-01-31 | Бёрингер Ингельхайм Ветмедика Гмбх | Способ получения вируса репродуктивно-респираторного сидрома свиней prrs |
EA038012B1 (ru) | 2011-02-17 | 2021-06-23 | Бёрингер Ингельхайм Ветмедика Гмбх | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
EP2737059A1 (en) | 2011-07-29 | 2014-06-04 | Boehringer Ingelheim Vetmedica GmbH | Novel prrs virus inducing type i interferon in susceptible cells |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
JP6386999B2 (ja) | 2012-05-17 | 2018-09-05 | ゾエティス・エルエルシー | ブタ生殖および呼吸症候群(prrs)ウイルスに対する離乳前の効果的なワクチン接種 |
CN105073130A (zh) | 2013-03-15 | 2015-11-18 | 勃林格殷格翰动物保健公司 | 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法 |
KR102319843B1 (ko) | 2013-09-25 | 2021-10-29 | 조에티스 서비시즈 엘엘씨 | Pcv2b 분지형 백신 조성물 및 사용 방법 |
EA039060B1 (ru) * | 2013-12-20 | 2021-11-29 | Бёрингер Ингельхайм Ветмедика Гмбх | Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс |
CN104198773A (zh) * | 2014-08-29 | 2014-12-10 | 苏州市吴中区胥口广博模具加工厂 | 三轴联动式大型电路板测试夹具的第二转轴组 |
TWI554609B (zh) * | 2014-11-19 | 2016-10-21 | 國立屏東科技大學 | 抗豬生殖與呼吸綜合症病毒感染之重組融合抗原基因、重組融合抗原蛋白及含彼之次單位疫苗組成物 |
KR20180042167A (ko) | 2015-08-31 | 2018-04-25 | 베링거잉겔하임베트메디카게엠베하 | 선천성 진전을 위한 페스티바이러스 백신 |
US10188725B2 (en) | 2015-12-14 | 2019-01-29 | Elanco Us Inc. | Hybrid core feline vaccines |
WO2018024677A1 (en) | 2016-08-05 | 2018-02-08 | Hipra Scientific, S.L.U. | PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS cDNA CLONE AND USES THEREOF |
CN110072547B (zh) | 2016-12-14 | 2024-04-30 | 硕腾服务有限责任公司 | 断奶前对抗欧洲猪繁殖与呼吸综合征(prrs)病毒株的有效疫苗接种 |
CN107586780B (zh) * | 2017-10-25 | 2019-10-11 | 中国农业科学院兰州兽医研究所 | 一种抑制猪繁殖与呼吸综合征病毒的长链非编码rna |
CN109943590B (zh) * | 2019-04-18 | 2022-11-18 | 西南大学 | 一种复制缺陷型猪圆环病毒、其制备方法及应用 |
CN111996174A (zh) * | 2020-02-06 | 2020-11-27 | 广西大学 | 猪繁殖与呼吸综合征病毒及其克隆载体和插入基因方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3137631A (en) | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
US3959457A (en) | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
US4015100A (en) | 1974-01-07 | 1977-03-29 | Avco Everett Research Laboratory, Inc. | Surface modification |
JPS5186117A (en) | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
US4205060A (en) | 1978-12-20 | 1980-05-27 | Pennwalt Corporation | Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use |
US4452747A (en) | 1982-03-22 | 1984-06-05 | Klaus Gersonde | Method of and arrangement for producing lipid vesicles |
US4744933A (en) | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
US5008050A (en) | 1984-06-20 | 1991-04-16 | The Liposome Company, Inc. | Extrusion technique for producing unilamellar vesicles |
US4921706A (en) | 1984-11-20 | 1990-05-01 | Massachusetts Institute Of Technology | Unilamellar lipid vesicles and method for their formation |
US4606940A (en) | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
US5009956A (en) | 1987-02-24 | 1991-04-23 | Univ Minnesota | Phospholipase A2-resistant liposomes |
IT8819772A0 (it) * | 1988-03-15 | 1988-03-15 | Honeywell Bull Spa | Dispositivo selettivo a terra per apparecchiature elettroniche. |
US4927637A (en) | 1989-01-17 | 1990-05-22 | Liposome Technology, Inc. | Liposome extrusion method |
US4944948A (en) | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
US5132117A (en) | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
HU218431B (hu) | 1991-06-06 | 2000-08-28 | Stichting Centraal Diergeneeskundig Instituut | A rejtélyes sertésvészt okozó Lelystad-vírus, a vírusból származtatható polipeptidek, antigének és nukleinsavak és rejtélyes sertésvész elleni vakcinakészítmények |
US5846805A (en) | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
MX9204885A (es) | 1991-08-26 | 1994-05-31 | Boehringer Animal Health Inc | Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos. |
US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
DK0601062T4 (da) | 1991-08-26 | 2001-03-14 | Univ Minnesota | SIRS-vaccine og diagnosefremgangsmåde |
AU2696792A (en) | 1991-09-16 | 1993-04-27 | David A Benfield | Vaccine for mystery swine disease and method for diagnosis thereof |
FR2686097B1 (fr) | 1992-01-14 | 1994-12-30 | Rhone Merieux | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
US5203054A (en) | 1992-09-28 | 1993-04-20 | Emhart Inc. | Retainer for trunk lid torsion bars |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6251397B1 (en) * | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6773908B1 (en) * | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
KR100374295B1 (ko) | 1993-02-08 | 2003-12-24 | 바이엘 코포레이션 | 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도 |
ES2074950B1 (es) | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
CA2187768A1 (en) | 1994-04-15 | 1995-10-26 | Moser, Charlotte A. | Aqueous solvent encapsulation method, apparatus and microcapsules |
CA2196555C (en) * | 1994-08-05 | 2012-07-03 | Michael P. Murtaugh | Vr-2332 viral nucleotide sequence and methods of use |
DK0732340T3 (da) | 1995-03-14 | 2004-10-25 | Akzo Nobel Nv | Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle |
ZA971663B (en) | 1996-03-01 | 1997-08-26 | Schering Corp | Porcine reproductive and respiratory syndrome vaccine. |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
WO1998055626A2 (en) | 1997-06-05 | 1998-12-10 | Origen, Inc. | Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine |
US6288199B1 (en) * | 1999-11-02 | 2001-09-11 | Ppg Industries Ohio, Inc. | Blocked isocyanate-based compounds and compositions containing the same |
-
1999
- 1999-11-23 NZ NZ51328999A patent/NZ513289A/xx not_active IP Right Cessation
- 1999-11-23 CA CA2290220A patent/CA2290220C/en not_active Expired - Lifetime
- 1999-11-23 CA CA 2440933 patent/CA2440933A1/en not_active Abandoned
- 1999-11-23 NZ NZ501264A patent/NZ501264A/en not_active IP Right Cessation
- 1999-11-24 ZA ZA9907289A patent/ZA997289B/xx unknown
- 1999-11-25 AT AT99309409T patent/ATE309364T1/de active
- 1999-11-25 DK DK05018141T patent/DK1627919T3/en active
- 1999-11-25 EP EP19990309409 patent/EP1018557B9/en not_active Expired - Lifetime
- 1999-11-25 DK DK99309409T patent/DK1018557T5/da active
- 1999-11-25 DE DE1999628209 patent/DE69928209T9/de active Active
- 1999-11-25 EP EP20050018141 patent/EP1627919B1/en not_active Expired - Lifetime
- 1999-11-25 PT PT05018141T patent/PT1627919E/pt unknown
- 1999-11-25 ES ES99309409T patent/ES2251162T3/es not_active Expired - Lifetime
- 1999-11-25 ES ES05018141T patent/ES2459568T3/es not_active Expired - Lifetime
- 1999-11-29 AU AU61733/99A patent/AU769841B2/en not_active Expired
- 1999-12-13 AR ARP990106325 patent/AR025146A1/es active IP Right Grant
- 1999-12-17 BR BRPI9905902A patent/BRPI9905902B8/pt not_active IP Right Cessation
- 1999-12-21 JP JP36218699A patent/JP4113642B2/ja not_active Expired - Lifetime
- 1999-12-22 US US09/470,661 patent/US6500662B1/en not_active Expired - Lifetime
- 1999-12-22 CN CNB99126505XA patent/CN1171996C/zh not_active Expired - Lifetime
-
2000
- 2000-12-06 JP JP2000372096A patent/JP4130729B2/ja not_active Expired - Lifetime
- 2000-12-06 JP JP2000372087A patent/JP4159242B2/ja not_active Expired - Lifetime
- 2000-12-28 HK HK00108442A patent/HK1029140A1/xx unknown
-
2002
- 2002-04-22 US US10/127,391 patent/US7232680B2/en not_active Expired - Lifetime
-
2003
- 2003-10-10 MX MXPA03009354 patent/MXPA03009354A/es active IP Right Grant
- 2003-10-22 JP JP2003362438A patent/JP2004081218A/ja not_active Withdrawn
-
2006
- 2006-02-07 CY CY061100160T patent/CY1105680T1/el unknown
-
2007
- 2007-03-30 AR ARP070101362 patent/AR058249A2/es not_active Application Discontinuation
-
2008
- 2008-01-28 JP JP2008016640A patent/JP2008113670A/ja active Pending
- 2008-02-19 JP JP2008037593A patent/JP4335287B2/ja not_active Expired - Lifetime
- 2008-05-27 JP JP2008137495A patent/JP2008289485A/ja active Pending
-
2014
- 2014-04-03 CY CY20141100252T patent/CY1115010T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115010T1 (el) | ΕΝΑΣ ΜΟΛΥΣΜΑΤΙΚΟΣ cDNA ΚΛΩΝΟΣ ΤΟΥ ΙΟΥ ΤΟΥ ΧΟΙΡΕΙΟΥ ΑΝΑΠΑΡΑΓΩΓΙΚΟΥ ΚΑΙ ΑΝΑΠΝΕΥΣΤΙΚΟΥ ΣΥΝΔΡΟΜΟΥ ΒΟΡΕΙΟΥ ΑΜΕΡΙΚΗΣ (PRRS) ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ | |
CA2196555A1 (en) | Vr-2332 viral nucleotide sequence and methods of use | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
DE69532369D1 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus | |
ES2141081T3 (es) | Nuevo aislado de hcv j-1. | |
NZ540544A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
EP0484787A3 (en) | Hcv-specific peptides, process for obtaining them and their use | |
ES2285832T3 (es) | Complejo de peptido antigenico-proteina de choque termico modificada. | |
ES2170622A1 (es) | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. | |
ATE309367T1 (de) | Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus | |
CY1106570T1 (el) | Σταθερες, εξασθενημενες μεταλλαγμενες μορφες ιου λυσσας και ζωντανια εμβολια αυτων | |
CY1106433T1 (el) | Εμβολια κοκκιδιωσης | |
ATE290399T1 (de) | Hbv/hcv virus-ohnliche particle | |
MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. | |
AUPM710194A0 (en) | Virus vector | |
ES2192433A1 (es) | Produccion del antigeno vp60, o de un fragmento del mismo, del virus de la enfermedad hemorragica de los conejos en plantas y vacuna contra la enfermedad hemorragica virica de los conejos que comprende dicho antigeno. | |
ATE453708T1 (de) | Impfstoff gegen west nile virus | |
NZ296304A (en) | Hepatitis c vaccine components | |
HUP0103871A2 (hu) | Rekombináns CELO-vírus és CELO vírus DNS | |
EP0924295A3 (en) | DNA encoding neospora dihydrofolate reductase-thymidylate synthase | |
DE69942611D1 (de) | Schützende hochmolekulargewichtsproteine aus haemophilus influenzae | |
TH51753B (th) | cDNA โคลน ที่ติดเชื้อของไวรัสกลุ่มอาการโรคเกี่ยวกับการสืบพันธ์และการหายใจของสุกร (PRRS) สายพันธ์อเมริกาเหนือและการใช้ cDNA โคลนนี้ | |
CO5400145A1 (es) | Proteina asociada con enfermedad | |
TH62970A (th) | วัคซีนไวรัสโรคเบอร์ซาอักเสบติดต่อชนิดบรอดสเปคตรัม (broad spectrum) | |
TH22679B (th) | การเอ็กซ์เพรสโพลีเพพไทด์ของไวรัสก่อโรคทางระบบหายใจที่แพร่พันธุ์ได้ในสุกรในเซลล์เดียวกัน |